Novel radiosensitizers for locally advanced epithelial tumors: Inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?RIESTERER, Oliver; TENZER, Angela; ZINGG, Daniel et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 2, pp 361-368, issn 0360-3016, 8 p.Conference Paper

Degradation of PKB/Akt protein by inhibition of the VEGF receptor/ mTOR pathway in endothelial cellsRIESTERER, Oliver; ZINGG, Daniel; HUMMERJOHANN, Jörg et al.Oncogene (Basingstoke). 2004, Vol 23, Num 26, pp 4624-4635, issn 0950-9232, 12 p.Article

Sulfate-Driven Elemental Sparing Is Regulated at the Transcriptional and Posttranscriptional Levels in a Filamentous CyanobacteriumGUTU, Andrian; ALVEY, Richard M; BASHOUR, Sami et al.Journal of bacteriology. 2011, Vol 193, Num 6, pp 1449-1460, issn 0021-9193, 12 p.Article

Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsZINGG, Daniel; RIESTERER, Oliver; FABBRO, Doriano et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5398-5406, issn 0008-5472, 9 p.Article

The phosphatidylinositide 3'-kinase/akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase CTENZER, Angela; ZINGG, Daniel; ROCHA, Sonia et al.Cancer research (Baltimore). 2001, Vol 61, Num 22, pp 8203-8210, issn 0008-5472Article